The emerging treatment of this peptide represents a significant development in the management of the condition. Unlike existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide568331.shotblogs.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56174729